G&S Capital’s Colgate-Palmolive CL Stock Holding History

G&S Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25,957	Closed	-$2.69M	–	122
2024 Q3	$2.69M	Buy	+25,957	New	+$2.65M	1.13%	32

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

G&S Capital's CL Position: Q4 2024 in Review

G&S Capital sold out of Colgate-Palmolive (CL) in Q4 2024, closing a stake of 25,957 shares — an estimated $2.69M sold.

G&S Capital first reported a position in CL in Q3 2024 and held it in 1 quarter. The position peaked at $2.69M in Q3 2024. 1,933 funds tracked by Wall St. Rank hold CL as of Q4 2024.

G&S Capital reported no remaining Colgate-Palmolive position as of Q4 2024 after selling out during the quarter.
G&S Capital sold 25,957 Colgate-Palmolive shares in Q4 2024, an estimated $2.69M.
G&S Capital first reported a position in Colgate-Palmolive in Q3 2024 and held it in 1 quarter.
G&S Capital's Colgate-Palmolive position peaked at $2.69M in Q3 2024.
1,933 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.

Based on G&S Capital's 13F filing for Q4 2024, filed 30 Jan 2025.